INTEGRA LIFESCIENCES HOLDINGS CORP

IART - CIK 0000917520

Market cap$1.34 B

Rank#2417

SEC filings2,094

INTEGRA LIFESCIENCES HOLDINGS CORP trades as IART and has a market capitalization of $1.34 B, making it the #2417 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.64B, up 1.5% from the prior year and net income of -$516.80M. This page tracks INTEGRA LIFESCIENCES HOLDINGS CORP through 2,094 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$1.64BFY 2025

Net income (latest FY)-$516.80MFY 2025

Operating cash flow (latest FY)$50.38MFY 2025

Total assets (latest FY)$3.60BFY 2025

Net margin-31.6%latest FY

Financial performance

Over the last 9 fiscal years INTEGRA LIFESCIENCES HOLDINGS CORP's revenue grew from $992.08M to $1.64B, a compound annual growth rate of 5.7%. Net profit margin compressed from 7.5% to -31.6% over the same period - every figure below comes from the company's audited annual filings.

IART annual revenueView details

Key statistics

Market cap: $1.34 B
Share price (derived)market cap / shares outstanding: $17.24
EPS (diluted)FY 2025: $-6.74
Shares outstandingas of 2026-05-04: 0.08B
Total equityas of 2026-03-31: $1.04B
Return on equity: -49.6%
Long-term debtas of 2026-03-31: $716.88M
Cash & equivalentsas of 2026-03-31: $236.81M

Latest filings

Filing	Type	Filed
SCHEDULE 13G	-	2026-05-15
Insider trade	4	2026-05-11
Insider trade	4	2026-05-11
Insider trade	4	2026-05-11
Insider trade	4	2026-05-11
Insider trade	4	2026-05-11
Insider trade	4	2026-05-11
Employee stock plan	S-8	2026-05-08

Browse the full filing history (2,094 filings)

Recent press releases

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference2026-06-02
Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference | Integra LifeSciences Holdings Corporation
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference2026-05-08
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference | Integra LifeSciences Holdings Corporation
Integra LifeSciences Reports First Quarter 2026 Financial Results2026-05-05
Integra LifeSciences Reports First Quarter 2026 Financial Results | Integra LifeSciences Holdings Corporation
Integra LifeSciences Announces Leadership Transition2026-05-05
Integra LifeSciences Announces Leadership Transition | Integra LifeSciences Holdings Corporation
Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 20262026-04-20
indispensable facts about motivation in the following paragraphs. If there’s at least one fact you didn’t know before, imagine the difference it migh

Similar companies

The largest companies sharing INTEGRA LIFESCIENCES HOLDINGS CORP's SEC industry classification (surgical & medical instruments & apparatus).

SYKStryker Corporation$117.82 B IART vs SYK

MMM3M Company$81.87 B IART vs MMM

BSXBoston Scientific Corporation$71.33 B IART vs BSX

MDLNMedline Inc.$49.12 B IART vs MDLN

BDXBecton, Dickinson and Company$41.03 B IART vs BDX

Frequently asked questions

What is INTEGRA LIFESCIENCES HOLDINGS CORP's market cap?

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) has a market capitalization of $1.34 B as of 2026-06-10, ranking #2417 among US-listed companies.

How much revenue does INTEGRA LIFESCIENCES HOLDINGS CORP make?

INTEGRA LIFESCIENCES HOLDINGS CORP reported revenue of $1.64B for fiscal year 2025, an increase of 1.5% year over year.

Is INTEGRA LIFESCIENCES HOLDINGS CORP profitable?

In its latest fiscal year INTEGRA LIFESCIENCES HOLDINGS CORP reported a net loss of $516.80M.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.